Atlas Trials

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Clinical trial NCT03144661 · TERMINATED

Trial details

NCT number
NCT03144661
Sponsor
Incyte Corporation
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal CancerNasopharyngeal CancerOvarian CancerSolid Tumors
Start date
2017-05-25
Primary completion
2020-06-10
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.